Advertisement

Breast Cancer Research and Treatment

, Volume 131, Issue 1, pp 223–229 | Cite as

Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancer

  • Tove F. TvedskovEmail author
  • Maj-Britt Jensen
  • Niels Kroman
  • Eva Balslev
Epidemiology

Abstract

Isolated tumor cells (ITC) are more common in the sentinel node (SN) after needle biopsy of a breast cancer, indicating iatrogenic displacement of tumor cells. We here investigate whether similar iatrogenic displacement occurs after surgical excision of a breast tumor. We compared the incidence of ITC in the SN of 414 breast cancer patients with recent surgical excision to a group of 16,960 patients without recent surgical procedure in a multivariate analysis by linking data from the Danish Breast Cancer Cooperative Group database and the Danish National Health Register. Moreover, the incidence of spread to non-SNs in patients with ITC in the SN after recent surgical excision was analyzed. We found an adjusted odds ratio on 3.73 (95% CI 2.57–5.43; P < 0.0001) for having ITC in the SN after surgical excision. The increase in ITC after surgical excision was especially seen in patients with ductal carcinomas (OR 4.66; 95% CI 3.03–7.19). None of the patients with ITC in SN after surgical excision had further spread to non-SNs compared to 12% in the group without recent surgical excision (P = 0.09). The nearly fourfold increase in ITC in the SN after surgical excision indicates that this procedure induces iatrogenic displacement of tumor cells. This displacement was more common in ductal carcinomas. We found no further dissemination to non-SNs in patients with ITC in the SN after recent surgical excision, and it is questioned whether these patients benefit from an axillary lymph node dissection.

Keywords

Breast cancer Sentinel lymph node Isolated tumor cells Iatrogenic displacement Surgical excision 

Notes

Acknowledgments

The study was supported by IMK common foundation, HOC research initiative foundation, the Danish cancer research foundation and A.P. Møller Foundation for the Advancement of Medical Science.

Conflicts of interest

None.

References

  1. 1.
    Chen SL, Hoehne FM, Giuliano AE (2007) The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 14:3378–3384PubMedCrossRefGoogle Scholar
  2. 2.
    Dowlatshahi K, Fan M, Snider HC, Habib FA (1997) Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 80:1188–1197PubMedCrossRefGoogle Scholar
  3. 3.
    Kuijt GP, Voogd AC, van de Poll-Franse LV, Scheijmans LJ, van Beek MW, Roumen RM (2005) The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol 31:500–505PubMedCrossRefGoogle Scholar
  4. 4.
    Grabau D, Jensen MB, Rank F, Blichert-Toft M (2007) Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival. APMIS 115:828–837PubMedCrossRefGoogle Scholar
  5. 5.
    Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH, Riethmuller G (2002) Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360:683–689PubMedCrossRefGoogle Scholar
  6. 6.
    van Deurzen CH, Bult P, de Boer M et al (2009) Morphometry of isolated tumor cells in breast cancer sentinel lymph nodes: metastases or displacement? Am J Surg Pathol 33:106–110PubMedCrossRefGoogle Scholar
  7. 7.
    van Deurzen CH, de Boer M, Monninkhof EM, Bult P, van der Wall E, Tjan-Heijnen VC, van Diest PJ (2008) Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst 100:1574–1580PubMedCrossRefGoogle Scholar
  8. 8.
    Christiansen P, Friis E, Balslev E, Jensen D, Moller S (2008) Sentinel node biopsy in breast cancer: five years experience from Denmark. Acta Oncol 47:561–568PubMedCrossRefGoogle Scholar
  9. 9.
    Husen M, Paaschburg B, Flyger HL (2006) Two-step axillary operation increases risk of arm morbidity in breast cancer patients. Breast 15:620–628PubMedCrossRefGoogle Scholar
  10. 10.
    Bleiweiss IJ, Nagi CS, Jaffer S (2006) Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 24:2013–2018PubMedCrossRefGoogle Scholar
  11. 11.
    Diaz NM, Cox CE, Ebert M et al (2004) Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Pathol 28:1641–1645PubMedCrossRefGoogle Scholar
  12. 12.
    Moore KH, Thaler HT, Tan LK, Borgen PI, Cody HS III (2004) Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact? Cancer 100:929–934PubMedCrossRefGoogle Scholar
  13. 13.
    Hansen NM, Ye X, Grube BJ, Giuliano AE (2004) Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg 139:634–639PubMedCrossRefGoogle Scholar
  14. 14.
    Moller S, Jensen MB, Ejlertsen B et al (2008) The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 47:506–524PubMedCrossRefGoogle Scholar
  15. 15.
    Singletary SE, Allred C, Ashley P et al (2002) Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:3628–3636PubMedCrossRefGoogle Scholar
  16. 16.
    Rostgaard K, Holst H, Mouridsen HT, Lynge E (2000) Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control 11:669–674PubMedCrossRefGoogle Scholar
  17. 17.
    Jensen AR, Storm HH, Moller S, Overgaard J (2003) Validity and representativity in the Danish Breast Cancer Cooperative Group—a study on protocol allocation and data validity from one county to a multi-centre database. Acta Oncol 42:179–185PubMedCrossRefGoogle Scholar
  18. 18.
    Nickelsen TN (2001) Data validity and coverage in the Danish National Health Registry. A literature review. Ugeskr Laeger 164:33–37PubMedGoogle Scholar
  19. 19.
    Kiaer HW, Laenkholm AV, Nielsen BB, Bjerre KD (2008) Classical pathological variables recorded in the Danish Breast Cancer Cooperative Group’s register 1978–2006. Acta Oncol 47:778–783PubMedCrossRefGoogle Scholar
  20. 20.
    Straver ME, Meijnen P, van Tienhoven G et al (2010) Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981–22023 AMAROS Trial. Ann Surg Oncol 17:1854–1861PubMedCrossRefGoogle Scholar
  21. 21.
    Carter BA, Jensen RA, Simpson JF, Page DL (2000) Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 113:259–265PubMedCrossRefGoogle Scholar
  22. 22.
    Mittendorf EA, Sahin AA, Tucker SL et al (2008) Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol 15:3369–3377PubMedCrossRefGoogle Scholar
  23. 23.
    Vincent-Salomon A, Caly M, De RY et al (2009) Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinoma. Eur J Cancer 45:1979–1986PubMedCrossRefGoogle Scholar
  24. 24.
    Diaz LK, Wiley EL, Venta LA (1999) Are malignant cells displaced by large-gauge needle core biopsy of the breast? AJR Am J Roentgenol 173:1303–1313PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2011

Authors and Affiliations

  • Tove F. Tvedskov
    • 1
    Email author
  • Maj-Britt Jensen
    • 2
  • Niels Kroman
    • 1
  • Eva Balslev
    • 3
  1. 1.Department of Breast Surgery, 3104Copenhagen University HospitalCopenhagenDenmark
  2. 2.Danish Breast Cancer Cooperative GroupCopenhagenDenmark
  3. 3.Department of PathologyHerlev HospitalHerlevDenmark

Personalised recommendations